Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $1,000 | 1 | 55.2% |
| Food and Beverage | $723.55 | 8 | 39.9% |
| Travel and Lodging | $88.94 | 1 | 4.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,000 | 1 | $0 (2022) |
| Glaukos Corporation | $271.99 | 3 | $0 (2023) |
| Aerie Pharmaceuticals, Inc. | $171.85 | 3 | $0 (2019) |
| Mobius Therapeutics, LLC | $126.90 | 1 | $0 (2017) |
| Alcon Laboratories Inc | $124.99 | 1 | $0 (2017) |
| Allergan Inc. | $116.76 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $183.05 | 2 | Glaukos Corporation ($183.05) |
| 2022 | $1,000 | 1 | ABBVIE INC. ($1,000) |
| 2019 | $62.73 | 2 | Aerie Pharmaceuticals, Inc. ($62.73) |
| 2018 | $109.12 | 1 | Aerie Pharmaceuticals, Inc. ($109.12) |
| 2017 | $457.59 | 4 | Mobius Therapeutics, LLC ($126.90) |
All Payment Transactions
10 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/21/2023 | Glaukos Corporation | iStent infinite Trabecular Micro-Bypass System Model iS3 (Device) | Food and Beverage | Cash or cash equivalent | $148.17 | General |
| Category: Glaucoma | ||||||
| 03/02/2023 | Glaukos Corporation | — | Food and Beverage | Cash or cash equivalent | $34.88 | General |
| 08/12/2022 | ABBVIE INC. | DURYSTA (Drug) | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| Category: GLAUCOMA | ||||||
| 05/13/2019 | Aerie Pharmaceuticals, Inc. | Rhopressa (Drug) | Food and Beverage | In-kind items and services | $48.15 | General |
| Category: Glaucoma | ||||||
| 05/13/2019 | Aerie Pharmaceuticals, Inc. | Rhopressa (Drug) | Food and Beverage | In-kind items and services | $14.58 | General |
| Category: Glaucoma | ||||||
| 12/21/2018 | Aerie Pharmaceuticals, Inc. | Rhopressa (Drug) | Food and Beverage | In-kind items and services | $109.12 | General |
| Category: Ophthalmology | ||||||
| 10/18/2017 | Mobius Therapeutics, LLC | Mitosol (Drug) | Food and Beverage | Cash or cash equivalent | $126.90 | General |
| Category: Ophthamology | ||||||
| 05/08/2017 | Alcon Laboratories Inc | — | Food and Beverage | In-kind items and services | $124.99 | General |
| 03/16/2017 | Glaukos Corporation | ISTENT TRABECULAR MICRO-BYPASS STENT SYSTEM (Device) | Travel and Lodging | Cash or cash equivalent | $88.94 | General |
| Category: Glaucoma | ||||||
| 03/03/2017 | Allergan Inc. | — | Food and Beverage | In-kind items and services | $116.76 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 504 | 574 | $60,335 | $19,934 |
| 2022 | 5 | 445 | 485 | $47,758 | $18,126 |
| 2021 | 7 | 497 | 557 | $51,646 | $21,473 |
| 2020 | 7 | 308 | 326 | $30,286 | $10,822 |
All Medicare Procedures & Services
28 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 142 | 192 | $32,104 | $12,513 | 39.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 53 | 59 | $5,487 | $2,574 | 46.9% |
| 92083 | Exam of visual field with extended testing | Facility | 2023 | 104 | 114 | $8,208 | $2,007 | 24.4% |
| 92133 | Imaging of optic nerve | Facility | 2023 | 111 | 115 | $10,695 | $1,610 | 15.1% |
| 92250 | Photography of the retina | Facility | 2023 | 38 | 38 | $1,140 | $468.99 | 41.1% |
| 92020 | Exam of the internal drainage system of eye | Facility | 2023 | 28 | 28 | $1,176 | $403.68 | 34.3% |
| 92136 | Measurement of corneal curvature and depth of eye | Facility | 2023 | 11 | 11 | $1,100 | $274.34 | 24.9% |
| 76514 | Ultrasound scan of cornea to determine thickness | Facility | 2023 | 17 | 17 | $425.00 | $84.11 | 19.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 133 | 156 | $21,970 | $10,400 | 47.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 70 | 77 | $7,161 | $3,486 | 48.7% |
| 92083 | Exam of visual field with extended testing | Facility | 2022 | 105 | 112 | $8,064 | $2,191 | 27.2% |
| 92133 | Imaging of optic nerve | Facility | 2022 | 98 | 101 | $9,393 | $1,518 | 16.2% |
| 92250 | Photography of the retina | Facility | 2022 | 39 | 39 | $1,170 | $531.76 | 45.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 130 | 159 | $22,260 | $11,680 | 52.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 78 | 94 | $8,742 | $4,386 | 50.2% |
| 92083 | Measurement of field of vision during daylight conditions, extended examination | Facility | 2021 | 90 | 101 | $7,272 | $2,093 | 28.8% |
| 92133 | Diagnostic imaging of optic nerve of eye | Facility | 2021 | 87 | 90 | $8,370 | $1,416 | 16.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 11 | 11 | $1,658 | $675.09 | 40.7% |
| 92020 | Examination of cornea and iris using lens device and slit lamp | Facility | 2021 | 36 | 37 | $1,554 | $541.69 | 34.9% |
| 92250 | Photography of the retina | Facility | 2021 | 33 | 33 | $990.00 | $484.38 | 48.9% |
| 76514 | Ultrasound of corneal structure and measurement | Facility | 2021 | 32 | 32 | $800.00 | $197.20 | 24.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 88 | 97 | $13,580 | $5,696 | 41.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 53 | 58 | $5,394 | $2,277 | 42.2% |
| 92083 | Measurement of field of vision during daylight conditions | Facility | 2020 | 55 | 59 | $4,248 | $1,117 | 26.3% |
| 92133 | Diagnostic imaging of optic nerve of eye | Facility | 2020 | 56 | 56 | $5,208 | $1,001 | 19.2% |
About Qi Cui, M.D., PH.D
Qi Cui, M.D., PH.D is a Glaucoma Specialist healthcare provider based in Philadelphia, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/11/2011. The National Provider Identifier (NPI) number assigned to this provider is 1013205145.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Qi Cui, M.D., PH.D has received a total of $1,812 in payments from pharmaceutical and medical device companies, with $183.05 received in 2023. These payments were reported across 10 transactions from 6 companies. The most common payment nature is "Consulting Fee" ($1,000).
As a Medicare-enrolled provider, Cui has provided services to 1,754 Medicare beneficiaries, totaling 1,942 services with total Medicare billing of $70,356. Data is available for 4 years (2020–2023), covering 28 distinct procedure/service records.
Practice Information
- Specialty Glaucoma Specialist
- Location Philadelphia, PA
- Active Since 07/11/2011
- Last Updated 04/11/2018
- Taxonomy Code 207WX0009X
- Entity Type Individual
- NPI Number 1013205145
Products in Payments
- DURYSTA (Drug) $1,000
- Rhopressa (Drug) $171.85
- iStent infinite Trabecular Micro-Bypass System Model iS3 (Device) $148.17
- Mitosol (Drug) $126.90
- ISTENT TRABECULAR MICRO-BYPASS STENT SYSTEM (Device) $88.94
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Glaucoma Specialist Doctors in Philadelphia
Rachel Niknam, Md, MD
Glaucoma Specialist — Payments: $153,221
Dilru Amarasekera
Glaucoma Specialist — Payments: $5,133
Dr. Alex Theventhiran, M.d, M.D
Glaucoma Specialist — Payments: $5,028
Jason Flamendorf, M.d, M.D
Glaucoma Specialist — Payments: $4,786
Stephen Moster, M.d, M.D
Glaucoma Specialist — Payments: $2,625
Reza Razeghinejad, M.d, M.D
Glaucoma Specialist — Payments: $1,823